GALACTICA Projects Pitch and Networking Event
Join us for the GALACTICA Projects Pitch and Networking Event on the 27th of October at 11:00-12:30 CEST for free! We are glad to invite you to attend the special
Join us for the GALACTICA Projects Pitch and Networking Event on the 27th of October at 11:00-12:30 CEST for free! We are glad to invite you to attend the special
The 22nd edition of the ESA Investor Forum will be held in Lisbon, on October 31st. The ESA Investor Forum is a high-profile event for space-related investment opportunities. It connects start-ups
The largest gathering of Africa-focused early stage investors is back for its 9th edition taking place from 2 - 4 November, 2022. This year the three-day Summit will be a
Do you want to invest in the next generation of startups and grow the economy? You've come to the right place. Review: "I would definitely recommend it to first-time startup investors,
Happening on the 7th and 8th November, Space Investment & Talent Day 2022 is a free-to-attend, hybrid event dedicated to space industry growth and networking. Things you can expect include: Start‐up
The DxPx Industry & Investor Conference is a dedicated partnering conference focusing on Diagnostics, Digital Health, Precision Medicine, and Life Science Tools. DxPx has an exclusive focus on these areas
If you are not already investing in AgriFood you are missing out! Discover AgriFood and its many exciting applications in this panel discussion by EBAN and AgTech7! You are invited to join the free
THE WORLD'S LEADING STARTUP EVENT HELSINKI, NOV 17–18, 2022 Slush is a student-driven, not-for-profit movement originally founded to change attitudes toward entrepreneurship. What started as a gathering of 300 local
Digital investment summit is a join industry initiative to matchmake promising Sri Lankan ICT companies and investor prospects. This industry initiative is led by Computer Society of Sri Lanka (CSSL)
Come and join the 11 th edition of BioFIT, on November 29 & 30 2022! With high attendance of TTOs, research institutes and academia together with big pharma, emerging and